Paper41873136
Bromophenol Derivatives as Multifunctional Antidiabetic Agents: Enzyme Inhibition Profiles and Induced-Fit Docking Analysis.
Gerni S. Biotechnol Appl Biochem, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Bromophenol Derivatives as Multifunctional Antidiabetic Agents: Enzyme Inhibition Profiles and Induced-Fit Docking Analysis. Papers, record 41873136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41873136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bromophenol Derivatives as Multifunctional Antidiabetic Agents: Enzyme Inhibition Profiles and Induced-Fit Docking Analysis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Molecular Docking Simulation | Major topic |
| Hypoglycemic Agents | Major topic |
| Aldehyde Reductase | Major topic |
| alpha-Amylases | Major topic |
| Enzyme Inhibitors | Major topic |
| Phenols | Major topic |
| Humans | |
| alpha-Glucosidases | |
| Structure-Activity Relationship |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34173346 | Alpha-amylase as molecular target for treatment of diabetes mellitus: A comprehensive review. | Chem Biol Drug Des | 2021 | https://conductscience.org/library/papers/34173346 | PubMed |
| 2 | 41196472 | Rhodanine-Sulfonate hybrids targeting aldose reductase: Synthesis, in vitro inhibition, molecular docking, and cytotoxicity studies. | Mol Divers | 2026 | https://conductscience.org/library/papers/41196472 | PubMed |
| 3 | 16500607 | A quantitative starch-iodine method for measuring alpha-amylase and glucoamylase activities. | Anal Biochem | 2006 | https://conductscience.org/library/papers/16500607 | PubMed |
| 4 | 34474201 | Cholinesterases, carbonic anhydrase inhibitory properties and in silico studies of novel substituted benzylamines derived from dihydrochalcones. | Comput Biol Chem | 2021 | https://conductscience.org/library/papers/34474201 | PubMed |
| 5 | 33749025 | Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities. | Arch Pharm (Weinheim) | 2021 | https://conductscience.org/library/papers/33749025 | PubMed |
| 6 | 31125830 | Inhibition effects of quinones on aldose reductase: Antidiabetic properties. | Environ Toxicol Pharmacol | 2019 | https://conductscience.org/library/papers/31125830 | PubMed |
| 7 | 36113601 | Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities. | Int J Biol Macromol | 2022 | https://conductscience.org/library/papers/36113601 | PubMed |
| 8 | 23649517 | Synthesis and biological evaluation of novel bromophenol derivatives as carbonic anhydrase inhibitors. | Arch Pharm (Weinheim) | 2013 | https://conductscience.org/library/papers/23649517 | PubMed |
| 9 | 36103032 | Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors. | Mol Divers | 2023 | https://conductscience.org/library/papers/36103032 | PubMed |
| 10 | 41016668 | 1,4-Naphthoquinone thiazole urea hybrids bearing morpholine/piperazine: synthesis, crystal structure, aldose reductase and α-glycosidase enzyme inhibition, molecular docking, and electrochemical interaction with dsDNA. | Bioorg Med Chem Lett | 2026 | https://conductscience.org/library/papers/41016668 | PubMed |
| 11 | 32544738 | Synthesis and screening of (E)-3-(2-benzylidenehydrazinyl)-5,6-diphenyl-1,2,4-triazine analogs as novel dual inhibitors of α-amylase and α-glucosidase. | Bioorg Chem | 2020 | https://conductscience.org/library/papers/32544738 | PubMed |
| 12 | 37529751 | Synthesis and antioxidant activities of benzylic bromophenols inclusive of natural products. | Turk J Chem | 2022 | https://conductscience.org/library/papers/37529751 | PubMed |
| 13 | 39039616 | A series of quinazolin-4(3H)-one-morpholine hybrids as anti-lung-cancer agents: Synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies. | Chem Biol Drug Des | 2024 | https://conductscience.org/library/papers/39039616 | PubMed |
| 14 | 39527602 | Lactoperoxidase Inhibition of Celecoxib Derivatives Containing the Pyrazole Linked-Sulfonamide Moiety: Antioxidant Capacity, Antimicrobial Activity, and Molecular Docking Studies. | J Biochem Mol Toxicol | 2024 | https://conductscience.org/library/papers/39527602 | PubMed |
| 15 | 26133541 | The effects of some bromophenols on human carbonic anhydrase isoenzymes. | J Enzyme Inhib Med Chem | 2016 | https://conductscience.org/library/papers/26133541 | PubMed |
| 16 | 14679173 | A radical explanation for glucose-induced beta cell dysfunction. | J Clin Invest | 2003 | https://conductscience.org/library/papers/14679173 | PubMed |
| 17 | 30076927 | Antidiabetic and antiparasitic potentials: Inhibition effects of some natural antioxidant compounds on α-glycosidase, α-amylase and human glutathione S-transferase enzymes. | Int J Biol Macromol | 2018 | https://conductscience.org/library/papers/30076927 | PubMed |
| 18 | 23579614 | Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. | J Comput Aided Mol Des | 2013 | https://conductscience.org/library/papers/23579614 | PubMed |
| 19 | 40581038 | Antidiabetic properties of dihydrooxazole Derivatives: In vitro and in silico evaluation as potential aldose reductase and α-glucosidase inhibitors. | Arch Biochem Biophys | 2025 | https://conductscience.org/library/papers/40581038 | PubMed |
| 20 | 32761859 | Determination of the inhibition profiles of pyrazolyl-thiazole derivatives against aldose reductase and α-glycosidase and molecular docking studies. | Arch Pharm (Weinheim) | 2020 | https://conductscience.org/library/papers/32761859 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AKR1B1 | 231 | PubTator's text mining | https://conductscience.org/library/genes/231 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41873136
GET https://conductscience.org/api/papers/v1/41873136/references?page=2